New Jersey Center for Cancer Research
Brick, NJ
Not currently accepting
IBI188
A Phase 1b Study Evaluating the Safety and Efficacy of IBI188 in Combination With Azacitidine in Subjects With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (MDS)
- Monoclonal Antibody
- Phase 1